Skip to Main Content
Pharmacist's Letter Canada
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • Natural Medicines Resources
  • CE & Training
    • CE Organizer
    • Available Courses
    • Live CE Calendar
    • Print Statements
    • Licenses
    • Additional Requirements
    • Exemptions
  • New Drugs
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Interactions
  4. Gastroenterology
  5. Antacids

Antacids

  • Bone & Joint (68)
  • Cardiology (284)
  • Dermatology (51)
  • Diabetes & Endocrinology (43)
  • Gastroenterology (85)
    • Antacids (22)
    • Cisapride (8)
    • H2 Receptor Antagonists (7)
    • Other (17)
    • PPIs (46)
  • Hematology & Oncology (6)
  • Infectious Diseases (236)
  • Men's Health (2)
  • Natural Medicines / Supplements / Food Interactions (147)
  • Neurology (126)
  • Nutrition & Obesity (9)
  • Psychiatry (146)
  • Resources (41)
  • Respiratory & Allergy (15)
  • Transplant Meds (14)
  • Women's Health (52)
1 - 15 of 22 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Chart: Antibiotics for MRSA Skin Infections December 2021
Chart: OTC Brand-Name Extensions July 2021
Article: Point Out Limitations of Alternate-Day Iron Dosing September 2020
Chart: Comparison of Oral Anticoagulants December 2019
Chart: New Formulation: Dovato (Dolutegravir-Lamivudine) November 2019
Article: Be Prepared to Discuss Dovato, a New Two-Med Combo for HIV November 2019
Article: Be Vigilant When Screening for Drug Interactions With Hep C Meds July 2019
Chart: Hepatitis C Treatment Overview July 2019
Article: Watch for the New Combo HIV Meds Symtuza and Biktarvy June 2018
Commentary: Symtuza Approved in Canada June 2018
Guideline: Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV, 2018 June 2018
Checklist: HIV Patient Transitions of Care Checklist May 2017
Article: Limit PPI Doses With New Hep C Med Epclusa September 2016
Article: Recommend Antacids WithOUT Aspirin for Patients at Risk for GI Bleeding August 2016
Patient Education: Take the “Burn” out of Heartburn July 2016
  • 1
  • 2
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • News and Resources
  • Products
  • Individual Solutions
  • Enterprise Solutions
© Therapeutic Research Center. All Rights Reserved